Advances in cystic fibrosis-related diabetes: Current status and future directions
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in cystic fibrosis-related diabetes: Current status and future directions
Authors
Keywords
-
Journal
Diabetes & Metabolic Syndrome-Clinical Research & Reviews
Volume 17, Issue 11, Pages 102899
Publisher
Elsevier BV
Online
2023-11-02
DOI
10.1016/j.dsx.2023.102899
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
- (2023) Carolin Steinack et al. Journal of Cystic Fibrosis
- The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis
- (2023) Andrea Granados et al. PEDIATRIC PULMONOLOGY
- A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis
- (2023) Kathryn J. Potter et al. DIABETES & METABOLISM
- New Concepts in the Pathogenesis of Cystic Fibrosis–Related Diabetes
- (2022) Amir Moheet et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Worldwide rates of diagnosis and effective treatment for cystic fibrosis
- (2022) Jonathan Guo et al. Journal of Cystic Fibrosis
- Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
- (2022) Insa Korten et al. Frontiers in Pediatrics
- Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis
- (2022) Claudia Piona et al. Journal of Clinical Medicine
- 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
- (2022) Nuha A. ElSayed et al. DIABETES CARE
- ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
- (2022) Katie Larson Ode et al. PEDIATRIC DIABETES
- Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
- (2021) Holly Gaines et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis
- (2021) Anne Bonhoure et al. DIABETOLOGIA
- Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
- (2021) C. Colombo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- CFTR Deficiency Affects Glucose Homeostasis via Regulating GLUT4 Plasma Membrane Transportation
- (2021) Junzhong Gu et al. Frontiers in Cell and Developmental Biology
- Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study
- (2021) Florence Racine et al. Canadian Journal of Diabetes
- Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance
- (2021) Andrea Kelly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-related Diabetes
- (2021) Kathryn J Potter et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- HOMA indices as screening tests for cystic fibrosis-related diabetes
- (2021) Tom Toin et al. Journal of Cystic Fibrosis
- The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
- (2021) Kevin J. Scully et al. Journal of Cystic Fibrosis
- Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis
- (2021) Kevin J Scully et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis
- (2021) Max C. Petersen et al. Journal of Cystic Fibrosis
- Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies
- (2021) Jessica E. Caterini et al. Journal of Cystic Fibrosis
- CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
- (2020) Miquéias Lopes-Pacheco Frontiers in Pharmacology
- Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients
- (2020) Bastien Misgault et al. Journal of Cystic Fibrosis
- Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
- (2020) Amir Moheet et al. Journal of Cystic Fibrosis
- Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function
- (2020) Claudia Piona et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
- (2019) Nataliya Volkova et al. Journal of Cystic Fibrosis
- Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis‐related diabetes
- (2019) F. Frost et al. DIABETIC MEDICINE
- Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis
- (2019) Andrea Granados et al. Journal of Cystic Fibrosis
- Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al
- (2019) Hanne V Olesen et al. Journal of Cystic Fibrosis
- Cystic Fibrosis Related Diabetes Screening in Adults: a Gap Analysis & Evaluation of A1C Accuracy
- (2018) Julie A. Gilmour et al. Canadian Journal of Diabetes
- Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure
- (2018) Rebecca L. Hull et al. DIABETES CARE
- Effect of Lumacaftor/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients
- (2018) Jan C. Thomassen et al. Journal of Cystic Fibrosis
- Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes
- (2018) Freddy Frost et al. Journal of Cystic Fibrosis
- β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL
- (2018) Sarah C Nyirjesy et al. PEDIATRIC DIABETES
- Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial
- (2018) Manfred Ballmann et al. Lancet Diabetes & Endocrinology
- Islet Hormone and Incretin Secretion in Cystic Fibrosis Following 4-months of Ivacaftor Therapy
- (2018) Andrea Kelly et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor
- (2018) Angel Li et al. Journal of Cystic Fibrosis
- Validation of a stepwise approach using A1c to reduce the number of required OGTT to screen for cystic fibrosis related diabetes in adults
- (2018) Valérie Boudreau et al. Canadian Journal of Diabetes
- Glucose-Sensitive CFTR Suppresses Glucagon Secretion by Potentiating KATP Channels in Pancreatic Islet α Cells
- (2017) Wen Qing Huang et al. ENDOCRINOLOGY
- Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
- (2017) Catherine Mainguy et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Ivacaftor for the p.Ser549Arg (S549R) gating mutation – The Israeli experience
- (2017) Adi Dagan et al. RESPIRATORY MEDICINE
- Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis
- (2016) Yaling Yi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges
- (2016) Valérie Boudreau et al. Canadian Journal of Diabetes
- HbA1c as a screening tool for cystic fibrosis related diabetes
- (2016) Juliana C. Burgess et al. Journal of Cystic Fibrosis
- Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes
- (2016) Valérie Boudreau et al. Journal of Cystic Fibrosis
- Classification of CFTR mutation classes
- (2016) Fernando Augusto Lima Marson et al. Lancet Respiratory Medicine
- Elevated Gluconeogenesis and Lack of Suppression by Insulin Contribute to Cystic Fibrosis-Related Diabetes
- (2016) Dana S. Hardin et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis
- (2015) Adèle Coriati et al. ACTA DIABETOLOGICA
- Retinal screening of patients with cystic fibrosis-related diabetes in Wales — A real eye opener
- (2015) R. Roberts et al. Journal of Cystic Fibrosis
- Elevation of one hour plasma glucose during oral glucose tolerance testing
- (2015) Saba Sheikh et al. PEDIATRIC PULMONOLOGY
- Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients
- (2013) A. Leclercq et al. Journal of Cystic Fibrosis
- Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test
- (2013) Kerstin Schmid et al. Journal of Cystic Fibrosis
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study
- (2013) Melena D Bellin et al. PEDIATRIC DIABETES
- Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children
- (2012) A. Parkkola et al. DIABETES CARE
- Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis-Related Diabetes: A technical review
- (2010) A. Moran et al. DIABETES CARE
- Impaired Fasting Glucose in Cystic Fibrosis
- (2010) B. I. Frohnert et al. DIABETES CARE
- Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society
- (2010) A. Moran et al. DIABETES CARE
- Oral glucose tolerance testing in children with cystic fibrosis
- (2010) Katie Larson Ode et al. PEDIATRIC DIABETES
- Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
- (2009) S. Hameed et al. DIABETES CARE
- Insulin Therapy to Improve BMI in Cystic Fibrosis-Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial
- (2009) A. Moran et al. DIABETES CARE
- Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
- (2009) A. Moran et al. DIABETES CARE
- A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis
- (2009) S. M. Blackman et al. DIABETOLOGIA
- Genetic Determinants and Epidemiology of Cystic Fibrosis-Related Diabetes: Results from a British cohort of children and adults
- (2008) A. I. Adler et al. DIABETES CARE
- Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance
- (2008) F. Moreau et al. HORMONE AND METABOLIC RESEARCH
- Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)
- (2008) Johanna M.W. van den Berg et al. Journal of Cystic Fibrosis
- Glucose Tolerance and Insulin Secretion, Morbidity, and Death in Patients with Cystic Fibrosis
- (2007) Elise Bismuth et al. JOURNAL OF PEDIATRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More